t-PA对人工晶体植入后瞳孔膜的治疗  

Treatment of pupillary exudative membrane with tissue plasminogen activator after intraocular lens implantation

作　　者：宋旭东[1] 施玉英[1] 陈松 

机构地区：[1]北京同仁医院眼科,100730

出　　处：《眼科》1996年第2期67-69,共3页Ophthalmology in China

摘　　要：白内障人工晶体植入术后可产生纤维蛋白渗出膜,作者采用前房注射t-PA(10μg)治疗瞳孔膜,观察t-PA的疗效和毒性。7例中,5例平均在1.3小时溶解(0.5～3小时),2例大部分溶解。其中2例前房有絮状渗出的瞳孔膜,注射后全部溶解,术后第一天复发。注药后2例出现眶周及患侧头痛,无角膜内皮毒性反应。Pupillary exudative membrane could occur after cataract extraction and intraocular lens implantation. Tissue plasminogen activator (10μg) was injected into the anterior chamber for treatment of the membrane, and its effect and toxicity were investigated. The membrane was dissolved completely in 5 of 7 eases in a mean time of 1.3 hours (0.5-3 hours), and dissolved partially in 2 cases. After the injection, on the second day the membrane recurred in 2eases, and headache and periorbital pain occurred on the involved side in 2 cases. No corneal endothelial toxic reaction was seen.

关 键 词：人工晶体植入术 瞳孔膜 纤维蛋白 溶酶原激活物 

分 类 号：R779.606[医药卫生—眼科] R973.2[医药卫生—临床医学]